View in EDS

Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphoma.
Authors: Calaud C; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Serrano-Lopez EM; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Cluse LA; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Todorovski I; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Mardivirin T; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Teater MR; Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY., Maarad A; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Tawfic N; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Fraser PJ; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Guiraud K; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Dupont C; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Menigot C; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France., Sant'Anna-Silva ACB; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France., Yoannidis D; Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Semple T; Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Kerreneur E; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France., Rocchi S; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France., Jacquel A; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France., Melnick AM; Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Barcelona, Spain., Johnstone RW; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Dominguez PM; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.
Source: Blood neoplasia [Blood Neoplasia] 2026 Mar 02; Vol. 3 (2), pp. 100214. Date of Electronic Publication: 2026 Mar 02 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42007249
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Calaud+C%22">Calaud C</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Serrano-Lopez+EM%22">Serrano-Lopez EM</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Cluse+LA%22">Cluse LA</searchLink>; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Todorovski+I%22">Todorovski I</searchLink>; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mardivirin+T%22">Mardivirin T</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Teater+MR%22">Teater MR</searchLink>; Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Maarad+A%22">Maarad A</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Tawfic+N%22">Tawfic N</searchLink>; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Fraser+PJ%22">Fraser PJ</searchLink>; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Guiraud+K%22">Guiraud K</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Dupont+C%22">Dupont C</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Menigot+C%22">Menigot C</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.<br /><searchLink fieldCode="AU" term="%22Sant'Anna-Silva+ACB%22">Sant'Anna-Silva ACB</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.<br /><searchLink fieldCode="AU" term="%22Yoannidis+D%22">Yoannidis D</searchLink>; Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Semple+T%22">Semple T</searchLink>; Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kerreneur+E%22">Kerreneur E</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.<br /><searchLink fieldCode="AU" term="%22Rocchi+S%22">Rocchi S</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.<br /><searchLink fieldCode="AU" term="%22Jacquel+A%22">Jacquel A</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.<br /><searchLink fieldCode="AU" term="%22Melnick+AM%22">Melnick AM</searchLink>; Institut de Recerca contra la Leucèmia Josep Carreras, Badalona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Johnstone+RW%22">Johnstone RW</searchLink>; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Dominguez+PM%22">Dominguez PM</searchLink>; Centre Méditerranéen de Médecine Moléculaire U1065, Université Côte d'Azur, INSERM, Nice, France.; Equipe Leader Fondation ARC 2023, Nice, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918841988906676%22">Blood neoplasia</searchLink> [Blood Neoplasia] 2026 Mar 02; Vol. 3 (2), pp. 100214. <i>Date of Electronic Publication: </i>2026 Mar 02 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918841988906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2950-3280 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503280%22">29503280 </searchLink><i>NLM ISO Abbreviation: </i>Blood Neoplasia <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42007249
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bneo.2026.100214
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100214
    Titles:
      – TitleFull: Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Calaud C
      – PersonEntity:
          Name:
            NameFull: Serrano-Lopez EM
      – PersonEntity:
          Name:
            NameFull: Cluse LA
      – PersonEntity:
          Name:
            NameFull: Todorovski I
      – PersonEntity:
          Name:
            NameFull: Mardivirin T
      – PersonEntity:
          Name:
            NameFull: Teater MR
      – PersonEntity:
          Name:
            NameFull: Maarad A
      – PersonEntity:
          Name:
            NameFull: Tawfic N
      – PersonEntity:
          Name:
            NameFull: Fraser PJ
      – PersonEntity:
          Name:
            NameFull: Guiraud K
      – PersonEntity:
          Name:
            NameFull: Dupont C
      – PersonEntity:
          Name:
            NameFull: Menigot C
      – PersonEntity:
          Name:
            NameFull: Sant'Anna-Silva ACB
      – PersonEntity:
          Name:
            NameFull: Yoannidis D
      – PersonEntity:
          Name:
            NameFull: Semple T
      – PersonEntity:
          Name:
            NameFull: Kerreneur E
      – PersonEntity:
          Name:
            NameFull: Rocchi S
      – PersonEntity:
          Name:
            NameFull: Jacquel A
      – PersonEntity:
          Name:
            NameFull: Melnick AM
      – PersonEntity:
          Name:
            NameFull: Johnstone RW
      – PersonEntity:
          Name:
            NameFull: Dominguez PM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 03
              Text: 2026 Mar 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2950-3280
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Blood neoplasia
              Type: main
ResultId 1